Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.
about
Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseasesTumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1αIdentification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis.Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAsMiR-592 inhibited cell proliferation of human colorectal cancer cells by suppressing of CCND3 expression.A critical role of mir-199a in the cell biological behaviors of colorectal cancerA systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma.MicroRNA-519a promotes proliferation and inhibits apoptosis of hepatocellular carcinoma cells by targeting FOXF2.Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2DDDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma.Understanding the role of NRF2-regulated miRNAs in human malignancies.MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein.microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C.miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives.Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma.MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human gliomaRegulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs.The impact of hepatitis B virus x protein and microRNAs in hepatocellular carcinoma: a comprehensive analysis.miR-214: a potential biomarker and therapeutic for different cancers.MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma.Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling.Strong reduction of AGO2 expression in melanoma and cellular consequences.MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways.MicroRNA profiles in various hepatocellular carcinoma cell lines.CDC25A targeting by miR-483-3p decreases CCND-CDK4/6 assembly and contributes to cell cycle arrest.MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7.Small Non-coding RNA Abundance in Adrenocortical Carcinoma: A Footprint of a Rare Cancer.Determining differentially expressed miRNAs and validating miRNA--target relationships using the SPRET/Ei mouse strain.Mir-592 regulates the induction and cell death-promoting activity of p75NTR in neuronal ischemic injury.Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.miR-708-5p: a microRNA with emerging roles in cancer.Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α.MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.Role of miR-483 in digestive tract cancers: from basic research to clinical value.
P2860
Q27024630-7915E1D2-6946-490F-8ADB-DA58FEB655A6Q30543779-EA921B3E-7110-4FBE-86A1-B368E397201CQ33698542-285A328F-BDC1-4AE9-93A6-7976B71A477BQ35342948-772F9CA4-F502-43D8-BF5E-8024E1D0F4BEQ35343911-5B146E54-8926-4E2F-893A-4576F13FB7B6Q35621551-D6C2ADD9-E3C6-4C7E-987E-5FB538F0C4EBQ35643577-DF574AC9-7AAB-4537-82DA-9B0658C81A71Q35770163-1E6DBB90-0F27-452C-A87A-FB950CE41E41Q36191096-5FE20187-3776-4FF3-B244-1C1C350CCB3EQ36320426-81B513B9-061A-4DB6-A290-8A4C61BC2CA3Q36413124-6F0BAC3B-01B3-4017-8330-DE8A68A5DA54Q36500050-C1524293-86A1-4090-AF41-CCDE0CC5CFC9Q37040124-0C5F48E1-52F9-4BFB-A24B-3D08FB0A6399Q37207646-4BEDC1ED-FA79-432C-BFBD-12A4BB154C32Q37213847-551DE82C-CD4F-4F2D-96B1-62BB48FAA694Q37309033-6532D9DF-CDFD-4336-9F3D-4BE18EC9249CQ37376524-34B9502A-E802-4737-BA06-7C4D7F51DCD7Q37581334-B3A164FB-1A11-49B1-8381-4726571B4E08Q37680071-28BF3F76-5DF5-45C7-8935-3FE4D01B95DFQ37706301-7B91D133-F2FD-4F09-B53D-599AA8962B0EQ38153384-A1B52744-A1ED-4725-9AFB-EFB1A7DC0A6AQ38257098-1855844A-DDF5-4698-9F47-B8BD20E5CA48Q38319595-BF1CA664-A7EE-4D21-89F1-48D131E9FFE2Q38807218-6C7D4D46-20A0-482D-A66B-3F5D208EF009Q38854666-EA4E16E1-3040-485A-9D56-FA85B2B890A5Q38858750-62C6CEF1-42D3-44B1-8A46-54ADB3A5D0E4Q39006701-07A57EEE-81C0-4D32-9595-DA14569546DAQ39069039-B7A11B8E-506B-479D-BB1F-7E39E4689168Q39240312-0EE89851-4BF2-4087-BE1B-D71166CF1D54Q39429036-67385F4C-56B8-4B96-A84B-52D778443D88Q40497578-B73217E2-96AE-41C6-B62D-A8552259FB11Q41642096-A3CB7252-B570-409B-89EF-7DECE949686AQ41700266-B78E6C7E-B0D1-4AA2-863D-89BCFDE6C40BQ41710131-38C2E68A-C3AF-4AC4-891E-0E4D9F8DE766Q41869127-72779E28-1252-420C-B846-622F8CCE4E43Q42223486-79541040-EFCF-436D-922F-772B3AA92392Q42378530-401B5C5B-509D-4FF8-B414-B4B0E8713D76Q45324940-DD13A4E3-2866-4C3F-B0A3-CF8CA4C8162EQ48837549-15DBF7F3-B742-40DF-9B70-26600EE623A0Q49313057-29AD8ED2-52F1-4B6A-A4CF-4E9426B5B124
P2860
Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Identification of deregulated ...... ated hepatocellular carcinoma.
@ast
Identification of deregulated ...... ated hepatocellular carcinoma.
@en
type
label
Identification of deregulated ...... ated hepatocellular carcinoma.
@ast
Identification of deregulated ...... ated hepatocellular carcinoma.
@en
prefLabel
Identification of deregulated ...... ated hepatocellular carcinoma.
@ast
Identification of deregulated ...... ated hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Identification of deregulated ...... ated hepatocellular carcinoma.
@en
P2093
Lan Juan Zhao
Ye-Xiong Tan
Zhong-Tian Qi
P2860
P304
P356
10.3748/WJG.V18.I38.5442
P407
P577
2012-10-01T00:00:00Z